CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Silver Hydrosol +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04144673
NCT04144673N/ACompleted
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Safety and Efficacy of Bio-Active Silver Hydrosol™ in Providing Immune Support

Natural Immunogenics Corp.·interventional·Posted Oct 30, 2019·Updated Apr 23, 2021

In Brief

A clinical study evaluating Silver Hydrosol and Placebo for Healthy. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The objective of this study is to investigate the ability of Bio-Active Silver Hydrosol™ in providing immune support in healthy adult males and females participating in intense aerobic exercise. Sixty eligible participants are planned to be randomized into either the investigational product or treatments arms and will consume the study product for 60 days (check-in visit on day 28). Questionnaires will be completed and blood and saliva samples will be collected to measure the endpoints.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 30, 2019
Enrollment StartNov 14, 2019
Primary CompletionJun 1, 2020
TodayJul 1, 2026
Enrollment to primary: 7 monthsPosted 6.7 years ago

Interventions

Silver Hydrosolother

Silver quantity will be 7 doses per day, with 50 mcg per dose.

Placeboother

Placebo water with no active ingredients